<p><h1>Pharmacovigilance (PV) Outsourcing Market Size, Share & Trends Analysis Report By Material, By Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030</h1></p><p><strong>Pharmacovigilance (PV) Outsourcing Market Analysis and Latest Trends</strong></p>
<p><p>Pharmacovigilance (PV) Outsourcing refers to the practice of contracting the activities related to pharmacovigilance to external service providers. Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The objective of outsourcing PV activities is to ensure regulatory compliance, reduce costs, and enhance efficiency.</p><p>The global Pharmacovigilance (PV) Outsourcing Market has been experiencing steady growth in recent years. Factors such as the increasing focus on patient safety, stringent regulations, and the rising complexity of drug development and approval processes are driving the growth of the market.</p><p>Furthermore, the growing volume of adverse drug events (ADEs) and the need for robust pharmacovigilance systems are also contributing to market growth. As pharmaceutical companies face challenges in managing their internal PV functions efficiently, they are increasingly opting for outsourcing PV activities to specialized service providers.</p><p>Moreover, the increasing adoption of technology solutions, such as AI and automation, in pharmacovigilance processes is expected to drive market growth. These technologies enable efficient data collection, processing, and analysis, leading to improved safety monitoring and faster adverse event reporting.</p><p>The Pharmacovigilance (PV) Outsourcing Market is expected to grow at a CAGR of 12.4% during the forecast period. This growth can be attributed to factors such as the increasing number of clinical trials, the rising focus on personalized medicine, and the growing awareness about drug safety among healthcare professionals and patients.</p><p>In conclusion, the Pharmacovigilance (PV) Outsourcing Market is expected to witness significant growth in the coming years. Factors such as the increasing focus on patient safety, regulatory compliance, and adoption of technology solutions are driving market growth.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1895074">https://www.reliableresearchreports.com/enquiry/request-sample/1895074</a></strong></p>
<p>&nbsp;</p>
<p><strong>Pharmacovigilance (PV) Outsourcing Major Market Players</strong></p>
<p><p>The pharmacovigilance (PV) outsourcing market is highly competitive, with several key players operating in the industry. Some of the major companies in this market include Accenture, C3i Solutions, Clintec, Covance, Deloitte Touche Tohmatsu Limited, ELC Group, Ergomed, iGATE Corporation, iMED Global Corporation, IQVIA, MarksMan Healthcare, Medpace Holdings, Novartis, Oracle Corporation, Parexel, PharmInvent, PrimeVigilance, Pure Drug Safety, Sciformix, SIRO Clinpharm, and Symogen.</p><p>One of the key players in the PV outsourcing market is Accenture. Accenture is a multinational professional services company that provides a wide range of services, including PV outsourcing solutions. The company has a strong global presence and a proven track record in the life sciences industry. Accenture has been actively involved in PV outsourcing for many years, working with leading pharmaceutical companies to ensure drug safety and regulatory compliance. The company provides end-to-end PV services, including case processing, medical review, aggregate reporting, signal detection, and risk management.</p><p>Another important player in the market is Covance. Covance is a global contract research organization (CRO) that offers a comprehensive suite of PV outsourcing services. The company has a strong reputation in the industry and a vast network of experts and resources. Covance provides a range of PV solutions, including literature surveillance, adverse event case management, safety database management, signal detection, and risk management. The company has experienced significant market growth over the years, driven by increasing demand for PV outsourcing services and its commitment to high-quality, efficient solutions.</p><p>One more notable player in the market is IQVIA. IQVIA is a leading provider of PV outsourcing services, with extensive experience in the field. The company offers a comprehensive suite of PV solutions, including case processing, medical review, aggregate reporting, signal detection, and risk management. IQVIA has a global presence and a strong track record in delivering high-quality PV services. The company has been witnessing steady market growth, driven by increasing demand for PV outsourcing and its innovative approach to drug safety.</p><p>It is important to note that specific sales revenue figures for the listed companies are proprietary information and may not be publicly available. However, the PV outsourcing market is expected to witness significant growth in the coming years. According to a report by Grand View Research, the global pharmacovigilance market is projected to reach USD 12.7 billion by 2025, growing at a CAGR of 13.0% from 2018 to 2025. The increasing focus on patient safety, stricter regulatory requirements, and the growing number of adverse drug events are driving the demand for PV outsourcing services.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Pharmacovigilance (PV) Outsourcing Manufacturers?</strong></p>
<p><p>The Pharmacovigilance (PV) Outsourcing market is witnessing remarkable growth due to various factors such as increasing government regulations, rising number of adverse drug events, and the complexity of pharmacovigilance activities. The market is expected to witness positive growth in the coming years, driven by advancements in technology and the need for efficient drug safety monitoring. The emergence of artificial intelligence and machine learning in PV outsourcing services is also expected to contribute to market growth. Additionally, the growing demand for pharmacovigilance services from biotechnology and pharmaceutical companies further propels the market's expansion. Overall, the PV outsourcing market is poised for significant growth in the foreseeable future.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1895074">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1895074</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Pharmacovigilance (PV) Outsourcing Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Contract Research Organizations (CROs)</li><li>Business Process Outsourcing (BPOs)</li></ul></p>
<p><p>Pharmacovigilance (PV) outsourcing refers to the practice of delegating drug safety monitoring tasks to external organizations. The contract research organization (CRO) market is one type of PV outsourcing, where companies specializing in clinical trial management and drug development handle pharmacovigilance activities. On the other hand, the business process outsourcing (BPO) market involves outsourcing various business functions, including pharmacovigilance, to service providers specialized in specific processes. Both CROs and BPOs offer expertise, infrastructure, and resources to ensure efficient pharmacovigilance operations for pharmaceutical companies.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1895074">https://www.reliableresearchreports.com/purchase/1895074</a></strong></p>
<p>&nbsp;</p>
<p><strong>The Pharmacovigilance (PV) Outsourcing Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Premarketing Clinical Trial</li><li>Post-marketing Clinical Practice</li><li>Other</li></ul></p>
<p><p>Pharmacovigilance (PV) outsourcing is the practice of contracting PV activities to external service providers. It finds application in various areas of the pharmaceutical industry. Firstly, during premarketing clinical trials, PV outsourcing involves monitoring and evaluating the safety and efficacy of drugs in development. After a drug is marketed, PV outsourcing extends to post-marketing clinical practice, where adverse events and drug-related incidents are reported, analyzed, and prevented. Additionally, PV outsourcing encompasses other markets, such as surveillance of medical devices, herbal products, vaccines, and veterinary drugs, ensuring continuous drug safety monitoring for improved patient care and regulatory compliance.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the Pharmacovigilance (PV) Outsourcing Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The pharmacovigilance (PV) outsourcing market has experienced significant growth in recent years across various regions. North America (NA), Europe, and the Asia Pacific (APAC) have emerged as lucrative markets for PV outsourcing due to the increasing demand for drug safety monitoring services. The United States (USA) and China, in particular, have witnessed remarkable expansion in their PV outsourcing sector. Currently, North America dominates the market with a market share of approximately 40%, followed by Europe at 30% and the APAC region at 20%. These regions are anticipated to continue dominating the market in the coming years, maintaining their respective market shares.</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1895074">https://www.reliableresearchreports.com/purchase/1895074</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1895074">https://www.reliableresearchreports.com/enquiry/request-sample/1895074</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://github.com/rahu1502/Market-Research-Report-List-1/blob/main/communications-and-media-software-market.md">Communications and Media Software Market</a></p><p><a href="https://medium.com/@juliusadams1991/electric-bus-charger-market-size-cagr-trends-2024-2030-4ca743ef7a51">Electric Bus Charger Market</a></p><p><a href="https://medium.com/@sylvanfahey/tires-market-size-market-outlook-and-market-forecast-2023-to-2030-5bab51ea349e">Tires Market</a></p><p><a href="https://github.com/rahu1505/Market-Research-Report-List-1/blob/main/polyacrylonitrile-pan-fiber-market.md">Polyacrylonitrile (PAN) Fiber Market</a></p><p><a href="https://medium.com/@walkersipes1943/air-suspension-solenoid-valve-market-size-market-outlook-and-market-forecast-2023-to-2030-c928e70f27e8">Air Suspension Solenoid Valve Market</a></p></p>